CSIMarket
 
Cyanotech Corp  (CYAN)
Other Ticker:  
 
 
Price: $0.2905 $-0.02 -6.592%
Day's High: $0.37 Week Perf: -6.59 %
Day's Low: $ 0.29 30 Day Perf: -56.64 %
Volume (M): 24 52 Wk High: $ 1.16
Volume (M$): $ 7 52 Wk Avg: $0.83
Open: $0.31 52 Wk Low: $0.19



 Market Capitalization (Millions $) 2
 Shares Outstanding (Millions) 7
 Employees 124
 Revenues (TTM) (Millions $) 20
 Net Income (TTM) (Millions $) -5
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Cyanotech Corp

We are a world leader in the production of high value natural products derived from microalgae. Incorporated in 1983, we are guided by the principle of providing beneficial, quality microalgal products for health and human nutrition in a sustainable, reliable and environmentally sensitive operation. We are GMP (Good Manufacturing Practices) certified by the Natural Products Association™, reinforcing our commitment to quality in our products, quality in our relationships (with our customers, suppliers, employees and the communities we live in), and quality of the environment in which we work. Our products include:


Hawaiian BioAstin® natural astaxanthin - a powerful dietary antioxidant shown to support and maintain the body’s natural inflammatory response, to enhance skin, and to support eye and joint health. It has expanding applications as a human nutraceutical and functional food ingredient; and


Hawaiian Spirulina Pacifica® - a nutrient-rich dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids

Microalgae are a diverse group of microscopic plants that have a wide range of physiological and biochemical characteristics and contain, among other things, high levels of natural protein, amino acids, vitamins, pigments and enzymes. Microalgae have the following properties that make commercial production attractive: (1) microalgae grow much faster than land grown plants, often up to 100 times faster; (2) microalgae have uniform cell structures with no bark, stems, branches or leaves, permitting easier extraction of products and higher utilization of the microalgae cells; and (3) the cellular uniformity of microalgae makes it practical to control the growing environment in order to optimize a particular cell characteristic. Efficient and effective cultivation of microalgae requires consistent light, warm temperatures, low rainfall and proper chemical balance in a very nutrient-rich environment, free of environmental contaminants and unwanted organisms. This is a challenge that has motivated us to design, develop and implement proprietary production and harvesting technologies, systems and processes in order to commercially produce human nutritional products derived from microalgae.

Our production of these products at the 90-acre facility on the Kona Coast of the island of Hawaii provides several benefits. We selected the Keahole Point location in order to take advantage of relatively consistent warm temperatures, sunshine and low levels of rainfall needed for optimal cultivation of microalgae. This location also offers us access to cold deep ocean water, drawn from an offshore depth of 2,000 feet, which we use in our Ocean-Chill Drying system to eliminate the oxidative damage caused by standard drying techniques and as a source of trace nutrients for microalgal cultures. The area is also designated a Biosecure Zone, with tight control of organisms allowed into the area and free of genetically modified organisms (GMO’s). We believe that our technology, systems, processes and favorable growing location generally permit year-round harvest of our microalgal products in a cost-effective manner.

Our Business

We operate entirely in one operating segment, the cultivation and production of microalgae into high-value, high-quality natural health and nutrition products. We cultivate, on a large-scale basis, two microalgal species from which our two major product lines, natural astaxanthin products and spirulina products, are derived. We record revenue and cost of sales information by product category, but do not record operating expenses by such product category.



   Company Address: 73-4460 Queen Kaahumanu Hwy. #102 Kailua-Kona 96740 HI
   Company Phone Number: 326-1353   Stock Exchange / Ticker: NASDAQ CYAN
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Cyanotech Corp

Cyanotech Corp's Deficit Widens on Sudden Sales Decline During Q3 2023 Earnings Season 2.

The stock market can be a volatile and unpredictable place, with companies constantly reporting their financial results and investors trying to make sense of it all. One such company that recently reported its fiscal period results is Cyanotech Corp, a producer of natural products derived from microalgae.
In the most recent fiscal period, Cyanotech reported a deficit per share of $-0.16, compared to $-0.10 in the same period a year prior. This represents a significant increase in losses for the company. Additionally, the revenue for the period declined by a staggering -19.344%, dropping from $5.76 million to $4.65 million. Sequentially, revenue fell even further by -23.637% from $6.09 million. These numbers reflect a challenging time for Cyanotech, as they struggle to maintain profitability and grow their top line.

Cyanotech Corp

Cyanotech Corp's Remarkable Recovery: Evanescence of Losses in the Latest Fiscal Period



Cyanotech Corp, a leading biotechnology company specializing in microalgae-based health and nutrition products, recently released its financial results for the most recent fiscal period. While the company has experienced a decrease in losses per share and a significant increase in revenue, there are mixed opinions about the future prospects of the company given its market and stock performance.
Financial Performance:
In the most recent fiscal period, Cyanotech Corp reported a decrease in its loss per share from $-0.15 to $-0.13, indicating an improvement compared to the previous year. Furthermore, the company's earnings per share (EPS) demonstrated substantial growth, with an increase from $-0.22 to $-0.13 per share in the prior reporting period.






 

Cyanotech's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com